Drugs designed for prostate cancer show promise for treating melanoma in men
New research shows that testosterone promotes melanoma proliferation by activating a newly recognized nonclassical testosterone receptor in melanoma cells called
Read more
New research shows that testosterone promotes melanoma proliferation by activating a newly recognized nonclassical testosterone receptor in melanoma cells called
Read moreThe risk of prostate cancer was 24% higher among 9/11 rescue and recovery workers after the attacks on the World
Read moreAfrican Americans have higher rates of prostate cancer and are more likely to die from the disease than other groups
Read moreProstate cancer is the second-most diagnosed cancer in men after skin cancer. Approximately 1 of 9 men in the U.S.
Read moreMultiparametric magnetic resonance imaging of the prostate (mpMRIp) is a promising tool for diagnosing prostate cancer, and prior to its
Read moreResearchers have developed a new pair of agents that show exceptional effectiveness for precision diagnosis and treatment of prostate cancer
Read moreLike security screening to make sure nothing harmful makes its way into a crowded area, cells in the human body
Read moreNewly diagnosed prostate cancer patients have multiple standard-of-care treatment options available, but many are not fully informed of their choices.
Read moreA new family of drugs which inhibit the activity of a protein associated with prostate and other cancers has been
Read moreA new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer,
Read more